Skip to main content
    D

    Dyadic International Inc (DYAI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.32
    -0.01 (-2.14%)

    Market Cap: $13.10M

    Last updated: Nov 17, 2026 at 10:46 AM ET

    Dyadic International Inc (DYAI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Dyadic International are Dare Bioscience (DARE), Intensity Therapeutics, Inc. Common stock (INTS) and Citius Pharmaceuticals (CTXR). By market cap, Dyadic International ranks 7th of the 13 companies on this page; Edesa Biotech (EDSA) is the largest at $26.21M.

    Peer Comparison

    DYAI's revenue growth of -0.6% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Dyadic International (DYAI)$13.10MN/A4.4x-200.5%-224.8%-0.6%0.00%
    Dare Bioscience Inc (DARE)$12.93MN/A6.4x0.0%N/A499.6%0.00%
    Intensity Therapeutics, Inc. Common stock (INTS)$10.17MN/AN/A0.0%N/A0.0%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    In8bio Inc (INAB)$8.86MN/AN/A0.0%N/A0.0%0.00%
    Vyome Holdings, Inc. (HIND)$11.09MN/AN/A0.0%N/A67.5%0.00%
    Tvardi Therapeutics, Inc. (TVRD)$15.74MN/AN/A0.0%N/A0.0%0.00%
    Biovie Inc (BIVI)$12.12MN/AN/A0.0%N/A0.0%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    Vyne Therapeutics Inc (VYNE)$19.07MN/AN/A0.0%N/A-57.4%0.00%
    Peer median$13.81MN/A6.4x0.0%-367.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Dyadic International, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Dare Bioscience Inc (DARE)
    Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States.
    DARE competitors
    Intensity Therapeutics, Inc. Common stock (INTS)
    Intensity Therapeutics, Inc. is a pioneering biotechnology firm committed to revolutionizing cancer treatment through cutting-edge drug delivery systems.
    INTS competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    In8bio Inc (INAB)
    IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers...
    INAB competitors
    Vyome Holdings, Inc. (HIND)
    Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States...
    HIND competitors
    Tvardi Therapeutics, Inc. (TVRD)
    Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet...
    TVRD competitors
    Biovie Inc (BIVI)
    BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States.
    BIVI competitors
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    Vyne Therapeutics Inc (VYNE)
    VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology.

    Frequently Asked Questions About DYAI

    Who are Dyadic International's main competitors?

    The companies most similar to Dyadic International include Dare Bioscience (DARE), Intensity Therapeutics, Inc. Common stock (INTS), Citius Pharmaceuticals (CTXR), Edesa Biotech (EDSA) and Pluri (PLUR), listed from the closest match.

    Who is Dyadic International's biggest competitor?

    Edesa Biotech (EDSA) is the largest of the similar companies at $26.21M; Dare Bioscience (DARE) is the closest match by business profile, size, sector and industry.

    How does DYAI stock compare with its competitors?

    DYAI's P/S is 4.4x against a peer median of 6.4x; its net margin is -200.5% against a peer median of 0.0%.

    Which of Dyadic International's competitors pays a higher dividend?

    Dyadic International pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Dyadic International bigger than its competitors?

    No. Dyadic International is 7th by market cap among the 13 companies on this page; the largest is Edesa Biotech (EDSA) at $26.21M.